Dr. Mulvihill is President and CEO of Actuated Medical, Inc. (AMI). Mulvihill co-founded AMI on the entrepreneurial idea that an agile business could solve clinical needs using electronically controlled motion.  Over the last 12 years, Mulvihill built a company that develops, manufactures and sells medical devices.  By establishing an ‘internal’ start-up ecosystem, her team has the infrastructure to incubate creative ideas and quickly test. Those ideas that demonstrate market potential are developed to commercial exits.   Knowing that FDA cGMP is key to technology valuation, AMI’s process is ISO 13485:2016 certified.  To endure the long timelines of medical device regulatory approvals and sales, AMI differentiates from others by using diverse financing model.    Implementing a stringent hiring process has led to 23 dedicated and engaged team members that apply their skills to multiple projects resulting in 20 issued patents and over 40 pending patent applications, and 3 products generating early revenue.  With the greater visibility, MedTech start-ups are coming to AMI for development assistance and/or IP out-licensing.  Within Pennsylvania, AMI is partnering with clinicians and researchers at Children’s Hospital of Philadelphia (CHOP), Penn State (PSU)-University Park, PSU-Hershey, PSU Children’s Hospital and University of Pittsburgh. 
This year, Mulvihill negotiated and signed a Vizient Nationwide Innovation contract for the TubeClear system – the innovation contract is highly regarded as few products achieve this recognition.   TubeClear has gained early adoption from several large hospitals across the. TubeClear’s market uniqueness attracted the attention of US regional distributors signing with AMI, thus expanding TubeClear’s nationwide sales force and doubling commercial revenue in 2018.
Mulvihill has been recognized over 34 times nationally and internationally for her entrepreneurial leadership. In 2017 she was a US delegate to the Global Entrepreneurship Summit in India.   Due to her experience growing a start-up, she was appointed to the AdvaMed Accel BOD to represent small emerging medical device companies.  She is an alumni of the competitive Goldman Sachs 10,000 Small Business program.  Mulvihill received her Ph.D. in Materials from Penn State in 1996.
Dr. Mulvihill has led multiple National Institutes of Health Small Business Innovation Research award projects and currently has funding through the Pennsylvania Pediatric Device Consortium to further develop and validate devices for clearing obstructing feeding tubes. This work includes collaboration with clinical, regulatory and market experts in the Pittsburgh and Philadelphia pediatric health innovation ecosystems.